CERE-120

· Sangamo Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CERE-120, covering 2012-08-14 to 2020-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease [Phase 1, Phase 2]